BC
Biopure Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by JUDELSON DAVID, was filed 09 Nov 2007.
Biopure Corp: what insiders have been doing
Every trade that managers of Biopure Corp disclose to SEC (Form 4) is tracked on this page. Nothing new has been filed by managers of Biopure Corp in twelve months, the latest record being from 26 November 2007.
Over the whole record (from 2006), the tally stands at 6 purchases and 1 sale.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
8
Thresholds
n/a
Buy Volume
€185,578
6 ops. · all time
Sell Volume
€492
1 ops. · all time
Financial data
· cache
Last declaration on 26 November 2007
Declarations8 total
- 1,140 shares@ US$0.6407Class A Common StockSEC:0001416278-07-000003:0
- 290,000 shares@ US$0.69Class A Common StockSEC:0000948982-07-000001:0Canonical exit: 6 Feb 2008 (T+90)
- 1,140 shares@ US$0.85Class A Common StockSEC:0001416278-07-000002:0Canonical exit: 4 Feb 2008 (T+90)
- 11,720 shares@ US$0.85Class A Common StockSEC:0001296303-07-000003:0Canonical exit: 4 Feb 2008 (T+90)
- 58,780 shares@ US$0.85Class A Common StockSEC:0001296303-07-000004:0Canonical exit: 4 Feb 2008 (T+90)
- 10,000 shares@ US$0.79Class A common stockSEC:0001222362-07-000001:0Canonical exit: 30 Jan 2008 (T+90)
- 5,000 shares@ US$0.55Class A CommonSEC:0001296303-07-000002:0Canonical exit: 16 Oct 2007 (T+90)
- 12,000 shares@ US$0.92Class A Common StockSEC:0001222362-06-000002:0
8 of 8 declarations
About Biopure Corp
Biopure Corp is a company listed on the XNAS market, specializing in the development of biopharmaceutical solutions. It focuses on innovation in the healthcare sector.
